For research use only. Not for therapeutic Use.
ER 50891 quarterhydrate(CAT: I040838) is a selective estrogen receptor antagonist known for its ability to inhibit estrogen-mediated cellular signaling. Presented as a quarterhydrate form, it offers improved consistency and handling in research applications. ER 50891 binds specifically to estrogen receptors (ERα and ERβ), blocking estrogen-driven transcriptional activity, making it a valuable tool for studying hormone-responsive cancers such as breast and endometrial cancer. It is also used to explore estrogen’s role in metabolic, cardiovascular, and neurological processes. This compound is ideal for receptor-binding assays, gene expression studies, and preclinical evaluations of estrogen-related pathways in endocrinology and oncology research.
| Molecular Formula | C29H24N2O2.1/4H2O |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
